ArticleO&G open2026
Diagnosis of Polycystic Ovary Syndrome With Predictive Modeling of Select Clinical Features.
Article in O&G open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Baseline Assessment of Dietary Intake and Physical Activity in Women With Polycystic Ovary Syndrome (PCOS)
Ultrasound Characterization of Ovarian Follicle Dynamics in Women With Amenorrhea
Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome
Ultrasonographic Evaluation of Anovulatory Disorders in Lean and Overweight Women
Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveTo determine whether a limited set of ultrasonographic, biochemical, and clinical features are sufficient to accurately predict polycystic ovary syndrome (PCOS) diagnosis.
methodsTransvaginal ultrasound images and available clinical data for participants with PCOS (n=101) and controls (n=50) were used for this multicenter, retrospective pilot study. Diagnosis of PCOS was defined by the 2023 International Evidence-Based Guideline. Controls had no diagnostic features of PCOS. Differences in demographic (age, body mass index [BMI]), ultrasonographic (ovarian volume, follicle number per ovary, follicle number per single cross section), biochemical (sex hormone binding globulin, total testosterone, free androgen index, bioavailable testosterone), and clinical (follicle-stimulating hormone, luteinizing hormone, estradiol, anti-müllerian hormone (AMH), age at menarche, minimum self-reported menstrual cycle length in the past year, maximum self-reported menstrual cycle length in the past year, Ferriman-Gallwey hirsutism score) features between groups were assessed with Mann-Whitney
resultsAnti-müllerian hormone alone predicted PCOS diagnosis with relatively good diagnostic accuracy (AUROC 0.884, F1 score 0.807). Integration of AMH and ovarian volume improved model performance (AUROC 0.906, F1 score 0.811). Integration of all ultrasonographic, biochemical, and clinical features yielded a high-performing model with excellent diagnostic accuracy for PCOS (AUROC 0.991, F1 score 0.811). Refinement of the model to a limited set of readily obtained variables, including AMH, ovarian volume, hirsutism score, and maximum self-reported menstrual cycle length, yielded a model with strong performance (AUROC 0.982, F1 score 0.805).
conclusionA minimum combination of ovarian volume with AMH and examination/history-derived end points can accurately predict PCOS diagnosis with performance comparable to that of a combination of all ultrasonographic, biochemical, and clinical features. This may streamline diagnostic workflows, thereby reducing clinical burden. PARENT PROTOCOL CLINICAL
trial registrationClinicalTrials.gov, NCT01859663, NCT01927471, NCT03306849, NCT01927432, NCT03547453.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.